Track topics on Twitter Track topics that are important to you
Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...
Paul A. Offit, MD, describes new research on a vaccine for shingles that could be a great step forward. Medscape Infectious Diseases
* Candidate vaccine for prevention of Shingles demonstrates overall efficacy of 97.2 pct which does not diminish in age groups studied
GlaxoSmithKline presented detailed data from a randomized phase 3 study of its investigational vaccine candidate for the prevention of shingles, HZ/su, showing vaccine efficacy was maintained across ...
Analysis of the primary endpoint showed a two-dose schedule of HZ/su reduced the risk of shingles by 97.2% (95% confidence interval [CI] 93.7-99.0) in adults aged 50 years and older compared with plac...
LONDON (Reuters) - An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the British drugmak...
GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage study. Data presented at a Copenhagen confere...
Phase 3 study results indicate that the HZ/su vaccine potentially offers more robust protection to the elderly and the immunocompromised than the existing vaccine. Medscape Optometry
Shingles vaccine Zostavax, from Sanofi Pasteur MSD, is now available across France, with national reimbursement…
Within a typical vaccine supply chain, vaccines are packaged into individual cylindrical vials (each containing one or more doses) that are bundled together in rectangular "inner packs" for transport ...
Tajikistan, considered highly endemic area for hepatitis B virus (HBV) in a pre-vaccine era, introduced hepatitis B vaccine in 2002 and reported ≥80% coverage with three doses of hepatitis B vaccine...
The efficacy and safety of ZOSTAVAX™ in subjects 60 years of age and older was established in the Shingles Prevention Study (SPS) and in subjects 50 to 59 years of age in the ZOSTAVAX™ Efficacy an...
In the article "Rule out pulmonary tuberculosis: Clinical and radiographic clues for the internist" (Curley CA. Cleve Clin J Med 2015; 82:32-38), on page 33, "Bacillus Calmette-Guérin vaccine" has be...